Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
14
References
17
Citations
NaN
KQI